Skip to content

Study · Not a test of the peptide alone · 2021

1 result

Refractory hypoglycaemia in a localised gastrointestinal stromal tumour: Case report.

Dhali A, Ray S, Dhali GK, Ghosh R, Sarkar A

International journal of surgery case reports26 May 2021Cited by 4 (Europe PMC)

PMID34090190 (opens in a new tab)PMCIDPMC8188391 (opens in a new tab)DOI10.1016/j.ijscr.2021.106023 (opens in a new tab)PepBankPUB-34090190
Read at sourcePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, GHRP-2 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking GHRP-2.

  1. 01HumanNot a test of GHRP-2 aloneCase report or seriesOther

    In a woman with a gastrointestinal stromal tumour and refractory hypoglycaemia, a GHRP‑2 assay showed an excessive reaction of basal growth hormone.

    In plain wordsIn one woman with a stomach-area tumour and low blood sugar, a GHRP‑2 test showed an excessive reaction of basal growth hormone.

    Peptide
    GHRP-2
    Outcome
    Not applicableBasal GH reaction in a GHRP-2 assay
    Study

    n = 1

    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones

    Source sentences

    Summary
    A growth hormone releasing peptide-2 (GHRP-2) assay was carried out which showed an excessive reaction of basal growth hormone however corticotropin releasing hormone (CRH) tests were within normal limits.
    1 context sentence
    Summary · context
    A 46 years old female with prime complain of awareness of a mass in the upper abdomen was admitted for evaluation and further management.

    In this study, GHRP-2 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-2.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.